A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2011
11/01/2011	US8048419 Extracorporeal cell-based therapeutic device and delivery system
11/01/2011	US8048418 Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists
11/01/2011	US8048417 Anti-human tenascin monoclonal antibody
11/01/2011	US8048416 Cytotoxicity mediation of cells evidencing surface expression of CD44
11/01/2011	US8048415 Compositions and methods for promoting or inhibiting angiogenesis
11/01/2011	US8048414 Antivenom composition containing Fab fragments
11/01/2011	CA2497008C Hydroxyalkylstarch-allergen conjugates
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2461662C Method and tools for oral hygiene
11/01/2011	CA2452986C Use of polyclonal anti-hiv goat serum as a therapeutic agent
11/01/2011	CA2447602C Anti-trail-r antibodies
11/01/2011	CA2402489C Oral tolerance induction by collagen to prevent allograft rejection
11/01/2011	CA2402247C Biodegradable immunomodulatory formulations and methods for use thereof
11/01/2011	CA2396718C Pre-transplant accomodated organs resistant to anti-donor immunity
11/01/2011	CA2380947C Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
11/01/2011	CA2366056C Non-spreading pestivirus
11/01/2011	CA2295986C Novel antimicrobial polypeptide and methods of use
11/01/2011	CA2279196C Antigenic inducer and substances prepared therefrom
10/2011
10/27/2011	WO2011133931A1 Use of il-27 antagonists for treating inflammatory bowel disease
10/27/2011	WO2011133925A2 Targeted and light-activated cytosolic drug delivery
10/27/2011	WO2011133919A1 Use of tau to monitor immunotherapy
10/27/2011	WO2011133897A2 Methods and materials for reducing liver fibrosis
10/27/2011	WO2011133894A2 Protein drug formulations and packages
10/27/2011	WO2011133886A2 Production of heteromultimeric proteins
10/27/2011	WO2011133879A2 Combination therapies with mitochondrial-targeted anti-tumor agents
10/27/2011	WO2011133867A2 Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
10/27/2011	WO2011133819A2 Methods of enhancing antibody-dependent cellular cytotoxicity
10/27/2011	WO2011133687A2 Methods and compositions for inhibition of beta2-adrenergic receptor degradation
10/27/2011	WO2011133685A2 Nanoparticle targeting to ischemia for imaging and therapy
10/27/2011	WO2011133559A2 Alpha tubulin acetyltransferase
10/27/2011	WO2011133429A1 Cancer-related glycopeptide epitopes, antibodies and methods of use
10/27/2011	WO2011133424A2 Genetic amplification of iqgap1 in cancer
10/27/2011	WO2011133210A2 A method treating breast cancer
10/27/2011	WO2011133105A1 Novel allergen
10/27/2011	WO2011132955A2 Use of hades as tumor suppressor target
10/27/2011	WO2011131789A1 A vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5
10/27/2011	WO2011131787A2 Antibody preparations
10/27/2011	WO2011131407A1 Antibodies against human csf-1r and uses thereof
10/27/2011	WO2011131208A1 Bivalent enterotoxemia vaccine for veterinary use
10/27/2011	WO2011130878A1 Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
10/27/2011	WO2011130859A1 Controlled release formulation based on hematin anhydride crystals for the induction of an innate immune reaction
10/27/2011	WO2011130800A1 Eczema treatment
10/27/2011	WO2011130799A1 Pharmaceutical compositions
10/27/2011	WO2011130798A1 Cold treatment
10/27/2011	WO2011109112A3 Method of detecting tau protein and tau fragments in serum
10/27/2011	WO2011106607A3 Subunit vaccines for herpes viruses and methods of use
10/27/2011	WO2011103490A3 INTEGRIN αVβ8 NEUTRALIZING ANTIBODY
10/27/2011	WO2011092593A3 Hiv-1 neutralizing antibodies and uses thereof
10/27/2011	WO2011084714A3 STABILIZED ANTI-TNF-ALPHA scFv MOLECULES OR ANTI-TWEAK scFv MOLECULES AND USES THEREOF
10/27/2011	WO2011072205A3 Genetic markers indicative of a cancer patient response to trastuzumab (herceptin)
10/27/2011	WO2011068894A3 Novel curcumin-antibody conjugates as anti-cancer agents
10/27/2011	WO2011068870A3 Modulation of nk cell antigen specific effector activity by modulation of cxcr6 (cd186)
10/27/2011	WO2011041003A3 Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
10/27/2011	WO2011040978A3 Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof
10/27/2011	WO2010115589A8 Trivalent, bispecific antibodies
10/27/2011	US20110265197 Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof
10/27/2011	US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof
10/27/2011	US20110263920 Advanced methods and systems for treating cell proliferation disorders
10/27/2011	US20110263822 Composition for the prophylaxis and treatment of hbv infections and hbv-mediated diseases
10/27/2011	US20110263517 Cytokines and Cytokine Receptors with Reduced Immunogenicity
10/27/2011	US20110262894 Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of hiv infections, antibodies and methods of diagnosis
10/27/2011	US20110262529 Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
10/27/2011	US20110262526 Method of inducing an anti-viral immune response
10/27/2011	US20110262525 Methods of treatment
10/27/2011	US20110262517 Chirally pure isomers of itraconazole and inhibitors of lanosterol 14a-demethylase for use as angiogenesis inhibitors
10/27/2011	US20110262491 Emulsions and methods of making nanocarriers
10/27/2011	US20110262488 Novel HIV-1 Envelope Glycoprotein
10/27/2011	US20110262484 Outer membrane vesicle prime-protein boost vaccine
10/27/2011	US20110262483 Methods for isolating enveloped virus-based vlps free of infectious agents
10/27/2011	US20110262482 Anti-viral compounds
10/27/2011	US20110262481 High growth reassortant influenza a virus
10/27/2011	US20110262480 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-GMP synthesis obtained by said method
10/27/2011	US20110262479 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
10/27/2011	US20110262478 Recombinant Protein Bodies as Immunogen-Specific Adjuvants
10/27/2011	US20110262477 Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins
10/27/2011	US20110262476 Mutant bacterial glycoproteins and uses thereof
10/27/2011	US20110262475 Lyme disease vaccine
10/27/2011	US20110262474 Chimeric HIV Antigens
10/27/2011	US20110262473 Synthetic vaccine component
10/27/2011	US20110262472 Vaccine compositions for the treatment of dengue fever and uses thereof
10/27/2011	US20110262471 Rab6kifl/kif20a epitope peptide and vaccines containing the same
10/27/2011	US20110262470 Immunoregulatory structures from normally occurring proteins
10/27/2011	US20110262469 Malaria vaccine based on fragments and combination of fragments of the cs protein of plasmodium vivax
10/27/2011	US20110262468 Method for Monitoring Vaccine Response Using Single Cell Network Profiling
10/27/2011	US20110262467 Novel Artificial Antigen Presenting Cells and Uses Therefor
10/27/2011	US20110262466 Compositions containing thrombomodulin domains and uses thereof
10/27/2011	US20110262465 Prostate stem cells and uses thereof
10/27/2011	US20110262464 Compositions, Kits, and Methods for the Diagnosis, Prognosis, and Monitoring of Cancer Using GOLPH3
10/27/2011	US20110262463 Syngr4 for target genes of cancer therapy and diagnosis
10/27/2011	US20110262462 Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
10/27/2011	US20110262461 Biological materials and uses thereof
10/27/2011	US20110262460 Blood-brain barrier targeting antibodies
10/27/2011	US20110262459 Neamine Compositions and Methods of Use Thereof
10/27/2011	US20110262458 Alzheimer's Disease Treatment Method
10/27/2011	US20110262457 Modulation of the immune response
10/27/2011	US20110262456 Method of treating ischemia reperfusion injury
10/27/2011	US20110262455 Treatment of proliferative disorders with a death receptor agonist
10/27/2011	US20110262454 Novel anti-cd38 antibodies for the treatment of cancer
10/27/2011	US20110262453 Markers for Assessing the Susceptibility of Cancer to IGF-1R Treatment
10/27/2011	US20110262452 Anti-hepsin antibodies and methods using same

1 ... 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 ... 1823